{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:13:04Z","timestamp":1760242384503,"version":"build-2065373602"},"reference-count":36,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T00:00:00Z","timestamp":1496361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>How hepatatitis C virus (HCV) infection affects the interplay among abundant adipokines in the host remains unclear. A prospective study was conducted with 450 consecutive genotype 1 (G1) and G2 HCV patients who completed a course of anti-HCV therapy and underwent pre-therapy and 24-week post-therapy surveys to assess various profiles and levels of abundant adipokines, including leptin, adiponectin, and plasminogen activator inhibitor-1 (PAI-1). Before anti-HCV therapy, multivariate analyses showed gender to be associated with leptin and adiponectin levels, and BMI with leptin and PAI-1 levels. Among patients with a sustained virological response (SVR, n = 372), associations at 24 weeks post-therapy were as follows: gender and BMI with all adipokine levels; hepatic steatosis and aspartate aminotransferase to platelet ratio index with adiponectin levels; and HOMA-IR and HCV genotype with PAI-1 levels. Paired t-tests revealed increased post-therapeutic PAI-1 levels in G1 SVR patients and decreased adiponectin levels in all SVR patients compared to pre-therapeutic levels. HCV infection may obscure associations between abundant adipokines and metabolic\/hepatic profiles. In SVR patients, a higher hierarchical status of PAI-1 versus adiponectin in affecting glucose metabolism was noted at 24 weeks post-therapy. Such genotype-non-specific adiponectin decreases and G1-specific PAI-1 increases warrant careful follow-up of HCV patients after SVR according to viral genotype.<\/jats:p>","DOI":"10.3390\/nu9060570","type":"journal-article","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T10:20:44Z","timestamp":1496398844000},"page":"570","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Evolving Interplay among Abundant Adipokines in Patients with Hepatitis C during Viral Clearance"],"prefix":"10.3390","volume":"9","author":[{"given":"Ming-Ling","family":"Chang","sequence":"first","affiliation":[{"name":"Liver Research Center, Division of Hepatology, Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan"},{"name":"Department of Medicine, College of Medicine, Chang Gung University, Taoyuan 33305, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsung-Hsing","family":"Chen","sequence":"additional","affiliation":[{"name":"Liver Research Center, Division of Hepatology, Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Ming","family":"Hsu","sequence":"additional","affiliation":[{"name":"Liver Research Center, Division of Hepatology, Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Hui","family":"Lin","sequence":"additional","affiliation":[{"name":"Liver Research Center, Division of Hepatology, Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Yu","family":"Lin","sequence":"additional","affiliation":[{"name":"Liver Research Center, Division of Hepatology, Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Jung","family":"Kuo","sequence":"additional","affiliation":[{"name":"Liver Research Center, Division of Hepatology, Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Wei","family":"Huang","sequence":"additional","affiliation":[{"name":"Liver Research Center, Division of Hepatology, Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Wei","family":"Chen","sequence":"additional","affiliation":[{"name":"Liver Research Center, Division of Hepatology, Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao-Tsai","family":"Cheng","sequence":"additional","affiliation":[{"name":"Liver Research Center, Division of Hepatology, Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chau-Ting","family":"Yeh","sequence":"additional","affiliation":[{"name":"Liver Research Center, Division of Hepatology, Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Tang","family":"Chiu","sequence":"additional","affiliation":[{"name":"Liver Research Center, Division of Hepatology, Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2017,6,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.26744","article-title":"Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource","volume":"59","author":"Smith","year":"2014","journal-title":"Hepatology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.3748\/wjg.v22.i4.1461","article-title":"Metabolic alterations and hepatitis C: From bench to bedside","volume":"22","author":"Chang","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tem.2009.07.005","article-title":"Hepatitis C virus hijacks host lipid metabolism","volume":"21","author":"Syed","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jhep.2016.01.025","article-title":"Metabolic interplay between white, beige, brown adipocytes and the liver","volume":"64","author":"Scheja","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/jgh.12705","article-title":"Plasminogen activator inhibitor-1 is independently associated with non-alcoholic fatty liver disease whereas leptin and adiponectin vary between genders","volume":"30","author":"Chang","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1749-6632.2010.05875.x","article-title":"Adipokines as novel biomarkers and regulators of the metabolic syndrome","volume":"1212","author":"Deng","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.3390\/ijms15046184","article-title":"Obesity and its metabolic complications: The role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease","volume":"15","author":"Jung","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1749-6632.1992.tb51595.x","article-title":"Immunoelectron microscopic localization of type 1 plasminogen activator inhibitor in the extracellular matrix of transforming growth factor-beta-activated endothelial cells","volume":"667","author":"Podor","year":"1992","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1381\/0960892053923789","article-title":"Changes in insulin resistance following bariatric surgery and the adipoinsular axis: role of the adipocytokines, leptin, adiponectin and resistin","volume":"15","author":"Ballantyne","year":"2005","journal-title":"Obes. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"11124","DOI":"10.1074\/jbc.M116.716431","article-title":"Leptin resistance contributes to obesity in mice with null mutation of carcinoembryonic antigen cell adhesion molecule 1","volume":"291","author":"Heinrich","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ajh.2010.216","article-title":"Adiponectin and hypertension","volume":"24","author":"Ohashi","year":"2011","journal-title":"Am. J. Hypertens."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.2337\/db14-0979","article-title":"Hepatic cyclooxygenase-2 expression protects against diet-induced steatosis, obesity, and insulin resistance","volume":"64","author":"Cucarella","year":"2015","journal-title":"Diabetes"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/ncpgasthep0186","article-title":"Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in nonalcoholic fatty liver disease","volume":"2","year":"2005","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.33549\/physiolres.930114","article-title":"The role of leptin in human physiology and pathophysiology","volume":"50","author":"Janeckova","year":"2001","journal-title":"Physiol. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1074\/jbc.M207198200","article-title":"Structure-function studies of the adipocyte-secreted hormone Acrp30\/adiponectin. Implications FPR metabolic regulation and bioactivity","volume":"278","author":"Pajvani","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.numecd.2016.12.005","article-title":"Translating the biology of adipokines in atherosclerosis and cardiovascular diseases: Gaps and open questions","volume":"27","author":"Ruscica","year":"2017","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3109\/02770903.2012.747101","article-title":"Leptin, adiponectin, and ghrelin levels in female patients with asthma during stable and exacerbation periods","volume":"50","author":"Tsaroucha","year":"2013","journal-title":"J. Asthma"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ejim.2012.06.013","article-title":"The plasma leptin\/adiponectin ratio predicts first cardiovascular event in men: a prospective nested case-control study","volume":"23","author":"Kappelle","year":"2012","journal-title":"Eur. J. Intern. Med."},{"key":"ref_19","first-page":"390185","article-title":"Altered Daytime Fluctuation Pattern of Plasminogen Activator Inhibitor 1 in Type 2 Diabetes Patients with Coronary Artery Disease: A Strong Association with Persistently Elevated Plasma Insulin, Increased Insulin Resistance, and Abdominal Obesity","volume":"2015","author":"Singh","year":"2015","journal-title":"Int. J. Endocrinol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1182\/blood-2013-05-427708","article-title":"Inflammation, obesity, and thrombosis","volume":"122","author":"Samad","year":"2013","journal-title":"Blood"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.4161\/cc.5.23.3510","article-title":"Senescence, wound healing and cancer: The PAI-1 connection","volume":"5","author":"Kortlever","year":"2006","journal-title":"Cell Cycle"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1182\/blood.V95.2.577","article-title":"Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice","volume":"95","author":"Eitzman","year":"2000","journal-title":"Blood"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00125-008-1135-4","article-title":"Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: Causal effect or epiphenomenon?","volume":"51","author":"Targher","year":"2008","journal-title":"Diabetologia"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"42503","DOI":"10.1038\/srep42503","article-title":"Link between plasminogen activator inhibitor-1 and cardiovascular risk in chronic hepatitis C after viral clearance","volume":"7","author":"Chang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Chang, M.L., Kuo, C.J., Huang, H.C., Chu, Y.Y., and Chiu, C.T. (2016). Association between Leptin and Complement in Hepatitis C Patients with Viral Clearance: Homeostasis of Metabolism and Immunity. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0166712"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Chang, M.L., Kuo, C.J., Pao, L.H., Hsu, C.M., and Chiu, C.T. (2017). The evolving relationship between adiponectin and insulin sensitivity in hepatitis C patients during viral clearance. Virulence.","DOI":"10.1080\/21505594.2017.1300734"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Chang, M.L., Tsou, Y.K., Hu, T.H., Lin, C.H., Lin, W.R., Sung, C.M., and Yeh, C.T. (2014). Distinct patterns of the lipid alterations between genotype 1 and 2 chronic hepatitis C patients after viral clearance. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0104783"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00726-016-2360-7","article-title":"Recovery of pan-genotypic and genotype-specific amino acid alterations in chronic hepatitis C after viral clearance: Transition at the crossroad of metabolism and immunity","volume":"49","author":"Chang","year":"2017","journal-title":"Amino Acids"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"30799","DOI":"10.1038\/srep30799","article-title":"Resistin reinforces interferon \u03bb-3 to eliminate hepatitis C virus with fine-tuning from RETN single-nucleotide polymorphisms","volume":"6","author":"Chang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.jhep.2016.01.009","article-title":"Increasing prevalence of cirrhosis among U.S. adults aware or unaware of their chronic hepatitis C virus infection","volume":"64","author":"Udompap","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1007\/s00125-009-1508-3","article-title":"Correlation of the leptin: Adiponectin ratio with measures of insulin resistance in non-diabetic individuals","volume":"52","author":"Finucane","year":"2009","journal-title":"Diabetologia"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.atherosclerosis.2010.03.024","article-title":"Carotid intima media thickness is associated with plasma adiponectin but not with the leptin:adiponectin ratio independently of metabolic syndrome","volume":"211","author":"Dullaart","year":"2010","journal-title":"Atherosclerosis"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ejim.2015.08.001","article-title":"Increased circulating adiponectin in males with chronic HCV hepatitis","volume":"26","author":"Canavesi","year":"2015","journal-title":"Eur. J. Intern. Med."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Valenti, L., Rametta, R., Ruscica, M., Dongiovanni, P., Steffani, L., Motta, B.M., and Magni, P. (2012). The I148M PNPLA3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls. BMC Gastroenterol., 12.","DOI":"10.1186\/1471-230X-12-111"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/eci.12280","article-title":"Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance","volume":"44","author":"Rametta","year":"2014","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/hep.24123","article-title":"Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C","volume":"53","author":"Valenti","year":"2011","journal-title":"Hepatology"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/9\/6\/570\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:37:43Z","timestamp":1760207863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/9\/6\/570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,2]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6]]}},"alternative-id":["nu9060570"],"URL":"https:\/\/doi.org\/10.3390\/nu9060570","relation":{},"ISSN":["2072-6643"],"issn-type":[{"type":"electronic","value":"2072-6643"}],"subject":[],"published":{"date-parts":[[2017,6,2]]}}}